Amgen Inc (NASDAQ:AMGN) traded in a range yesterday that spanned from a low of $180.12 to a high of $183.40. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $181.25 on volume of 792,000 …
After a district court ruled in favor of Amgen Inc. AMGN, -0.63% in two patent claims, Regeneron Pharmaceuticals Inc. REGN, -1.81% and Sanofi SA said Wednesday they disagreed and would appeal the judgment. The lawsuit's dispute …
Clovis, Sage and Puma could stoke acquisitive appetites in 2018 as large-cap biotechs struggle with slowing growth and major patent cliffs, analysts said Tuesday.
A federal judge rejected Amgen Inc.'s effort to temporarily block a competitor from releasing a copycat version of one of its top-selling biologic drugs. The Thousand Oaks biotech company had accused Novartis subsidiary Sandoz of violating …
By Mr. Loeb’s reckoning, a breakup could yield significant results. Given its current corporate self-help plan, Amgen appears set to improve its stock’s valuation to $189 a share by the end of 2016. But if the company splits itself in two, …
NEW YORK (CNNfn) - Top money managers and analysts appeared on CNNfn this week to discuss the stocks they're buying and why. Here's a brief rundown of those recommendations, culled from CNNfn.com's daily feature, "Stock